SecBot SecBot
SECBOTREPLAY Home › Report › LXRX

LXRX · Lexicon Pharmaceuticals entered into a $100 million loan facility with…

LEXICON PHARMACEUTICALS, INC. · 8-K filed May 6, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 4/10

8-K filed May 6, 2026 at 16:01 ET

Lexicon Pharmaceuticals entered into a $100 million loan facility with Hercules Capital, with $55 million funded at closing to repay existing debt. The facility provides non-dilutive capital with an 18-month interest-only period (extendable to 30 months upon milestones) and matures in May 2030. Warrants for 691,823 shares were issued to Hercules, representing modest dilution.

  • Loan facility of up to $100 million from Hercules Capital, $55 million funded at closing
  • Funds used to repay existing Oxford Finance loan
  • Interest rate: prime rate + 3.10%, floor 9.85%
  • Interest-only period: 18 months, extendable to 30 months upon clinical/regulatory milestones

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access